ArticleCancer medicine2017

Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.

Yuelong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.